{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:11:30Z","timestamp":1764238290894,"version":"3.41.2"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004809","name":"California Office of Traffic Safety","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Toxicol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Motor vehicle crashes (MVCs) are a major global health concern. While alcohol continues to be a significant contributor to MVCs, the role of illicit and prescription drugs has increased in the last 4\u00a0decades. Moreover, the proliferation of new psychoactive substances (NPS) in the United States since 2010 has reshaped recreational drug use. Despite this, its contribution to MVCs has not been systematically evaluated. In this study, we report the prevalence of NPS in roadway crash victims in California.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum samples from 1000 roadway crash victims were collected and analyzed using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF\/MS) against a comprehensive database of 1314 drugs, including 1008 NPS, and quantitative analysis was performed using isotope dilution. Alcohol was quantified in an autoanalyzer using an enzymatic method employing alcohol dehydrogenase.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eight NPS (detection frequency = 26) were confirmed and quantified in 17 cases. Like current nationwide NPS surveillance studies, bromazolam, para-fluorofentanyl, and mitragynine were most frequently detected. NPS were detected in polypharmacy use, with traditional recreational drugs such as fentanyl, methamphetamine, and delta-9 THC most frequently co-detected. The serum geometric means detected for bromazolam (5.41\u00a0ng\/mL; range: 0.22\u201326.59), para-fluorofentanyl (0.45\u00a0ng\/mL; range: 0.28\u20132.02) and mitragynine (7.02; range: 0.55\u201390.55) were lower than those reported for overdose and death cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study is the first to report quantitative levels of multiple NPS and multiple NPS classes in a large US roadway crash survey, with the high detection of CNS depressants and their co-occurrence with traditional recreational drugs highlighting the need for expanded NPS testing, roadside testing strategies, and guidelines for determining drug-induced impairment; the quantitative data may be valuable in establishing these guidelines.<\/jats:p><\/jats:sec>","DOI":"10.3389\/ftox.2025.1572324","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T05:25:42Z","timestamp":1750829142000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["New psychoactive substances in roadway crash victims in California"],"prefix":"10.3389","volume":"7","author":[{"given":"Roy","family":"Gerona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Tomer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donovan","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allyson C.","family":"Sage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Tolles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Alan","family":"Chenoweth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/jat\/bkae074","article-title":"Bromazolam in impaired driving investigations","volume":"48","author":"Bierly","year":"2024","journal-title":"J. Anal. Toxicol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"100224","DOI":"10.1016\/j.fsisyn.2022.100224","article-title":"Driving under the influence of drugs: correlation between blood psychoactive drug concentrations and cognitive impairment. A narrative review taking into account forensic issues","volume":"4","author":"Blandino","year":"2022","journal-title":"Forensic Sci. Int. Synerg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/aje\/kwt327","article-title":"Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999-2010","volume":"179","author":"Brady","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0376-8716(89)90021-5","article-title":"Drugs of abuse found in fatally injured drivers in Los Angeles County","volume":"23","author":"Budd","year":"1989","journal-title":"Drug Alcohol Depend."},{"key":"B5","doi-asserted-by":"publisher","first-page":"430248","DOI":"10.1155\/2015\/430248","article-title":"A review of the updated pharmacophore for the Alpha 5 GABA(A) benzodiazepine receptor model","volume":"2015","author":"Clayton","year":"2015","journal-title":"Int. J. Med. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2165\/11539050-000000000-00000","article-title":"Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence","volume":"34","author":"Dassanayake","year":"2011","journal-title":"Drug Saf."},{"key":"B7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/jat\/bkab064","article-title":"Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities-2021 update","volume":"45","author":"D\u2019Orazio","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/jat\/bkw054","article-title":"An impaired driver found to be under the influence of methoxetamine","volume":"40","author":"Fassette","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/dta.2897","article-title":"Retrospective analysis of new psychoactive substances in blood samples of German drivers suspected of driving under the influence of drugs","volume":"12","author":"Fels","year":"2020","journal-title":"Drug Test. Anal."},{"key":"B10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/bs.acc.2022.08.001","article-title":"Drug testing in the era of new psychoactive substances","volume":"111","author":"Gerona","year":"2022","journal-title":"Adv. Clin. Chem."},{"year":"2011","author":"Hels","article-title":"Risk of injury by driving with alcohol and other drugs","key":"B11"},{"key":"B12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1520\/jfs11976j","article-title":"Designer drugs: past history and future prospects","volume":"33","author":"Henderson","year":"1988","journal-title":"J. Forensic Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/1060028014520882","article-title":"Medications and impaired driving","volume":"48","author":"Hetland","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"111325","DOI":"10.1016\/j.forsciint.2022.111325","article-title":"Drug consumption of suspected drug-influenced drivers in Hungary (2016-2018)","volume":"336","author":"Instit\u00f3ris","year":"2022","journal-title":"Forensic Sci. Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/jat\/bkad066","article-title":"Mitragynine in the Orange county DUID population","volume":"47","author":"Kedzierski","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1111\/1556-4029.12550","article-title":"Driving under the influence of synthetic cannabinoid receptor agonist XLR-11","volume":"59","author":"Lemos","year":"2014","journal-title":"J. Forensic Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.aap.2013.09.001","article-title":"Drug use and fatal motor vehicle crashes: a case-control study","volume":"60","author":"Li","year":"2013","journal-title":"Accid. Anal. Prev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jat\/bkx082","article-title":"Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities-2017 update","volume":"42","author":"Logan","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/jat\/bkt059","article-title":"Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities","volume":"37","author":"Logan","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3109\/15563650.2016.1139714","article-title":"Non-targeted screening for novel psychoactive substances among agitated emergency department patients","volume":"5","author":"Lung","year":"2016","journal-title":"Clin. Toxicol. Feb"},{"unstructured":"Alcohol, other drug, and multiple drug use among drivers\n          \n          \n          2022","key":"B21"},{"key":"B22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/jat\/bkad036","article-title":"Increasing prevalence of designer benzodiazepines in impaired driving: a 5-year analysis from 2017 to 2021","volume":"47","author":"Papsun","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1080\/15563650.2019.1569236","article-title":"Kratom exposures reported to United States poison control centers: 2011-2017","volume":"57","author":"Post","year":"2019","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B24","first-page":"792","article-title":"Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects","volume":"112","author":"Prozialeck","year":"2012","journal-title":"J. Am. Osteopath Assoc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/1556-4029.13433","article-title":"Drug recognition evaluation and chemical confirmation of a 25C-NBOMe-Impaired driver","volume":"62","author":"Rajotte","year":"2017","journal-title":"J. Forensic Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/jat\/bks037","article-title":"The mirage of impairing drug concentration thresholds: a rationale for zero tolerance per se driving under the influence of drugs laws","volume":"36","author":"Reisfield","year":"2012","journal-title":"J. Anal. Toxicol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1093\/jat\/bky101","article-title":"Prevalence of new psychoactive substances in oral fluid specimens from French and Belgian drivers: comparison 2016\/2017","volume":"43","author":"Richeval","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1002\/(sici)1099-1077(1998110)13:2+<s49::aid-hup49>3.3.co;2-t","article-title":"Mechanisms of drug-induced driving impairment: a dimensional approach","volume":"13","author":"Riedel","year":"1998","journal-title":"Hum. Psychophamacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.aap.2014.04.003","article-title":"Trends in drug use among drivers killed in U.S. traffic crashes, 1999\u20132010","volume":"70","author":"Rudisill","year":"2014","journal-title":"Accid. Anal. Prev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.remle.2017.11.008","article-title":"Driving under the influence of new psychoactive substances","volume":"44","author":"Soria","year":"2018","journal-title":"Span. J. Leg. Med."},{"volume-title":"Drug prevalence among seriously or fatally injured road users (Report No. DOT HS 813 399)","year":"2022","author":"Thomas","key":"B31"},{"key":"B46","first-page":"153","article-title":"Notes from the field: increased incidence of fentanyl-related deaths involving para-fluorofentanyl or metonitazene - Knox County, Tennessee, November 2020-August 2021","volume-title":"MMWR Morb. Mortal. Wkly","author":"Trecki","year":"2022"},{"year":"2024","doi-asserted-by":"publisher","article-title":"Road safety","key":"B32","DOI":"10.1007\/978-981-97-4618-7_300722"},{"year":"2020","journal-title":"National Forensic Laboratory information System: NFLIDrug 2019 Annual Report","key":"B45"},{"unstructured":"NPS data visualizations\n          \n          \n          2025","key":"B33"},{"volume-title":"DEA TOX: 2022 annual report","year":"","key":"B34"},{"volume-title":"DEA TOX: quarterly report - first quarter 2023","year":"","key":"B35"},{"volume-title":"DEA TOX: quarterly report - second quarter 2023","year":"","key":"B36"},{"volume-title":"DEA TOX: quarterly report - third quarter 2023","year":"","key":"B37"},{"volume-title":"DEA TOX: quarterly report - fourth quarter 2023","year":"","key":"B38"},{"key":"B39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/dta.2232","article-title":"Prevalence of new psychoactive substances and prescription drugs in the Belgian driving under the influence of drugs population","volume":"10","author":"Wille","year":"2018","journal-title":"Drug Test. Anal."},{"key":"B48","first-page":"19","article-title":"Drugs in fatally injured young male drivers","volume":"100","author":"Williams","year":"1985","journal-title":"Public Health Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/003335491412900409","article-title":"Fatal crashes from drivers testing positive for drugs in the U.S., 1993-2010","volume":"129","author":"Wilson","year":"2014","journal-title":"Public Health Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/bcp.14236","article-title":"The challenge of the novel psychoactive substances: how have we responded and what are the implications of this response?","volume":"86","author":"Wood","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1093\/jat\/bky028","article-title":"Suspected driving under the influence case involving mitragynine","volume":"42","author":"Wright","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3109\/15563650.2012.713108","article-title":"Role of liquid chromatography-high-resolution mass spectrometry (LC-HR\/MS) in clinical toxicology","volume":"50","author":"Wu","year":"2012","journal-title":"Clin. Toxicol. (Phila)."},{"key":"B44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neuro.2019.02.015","article-title":"An expanding world of new psychoactive substances-designer benzodiazepines","volume":"73","author":"Zawilska","year":"2019","journal-title":"Neurotoxicology"}],"container-title":["Frontiers in Toxicology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2025.1572324\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T05:25:46Z","timestamp":1750829146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2025.1572324\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":48,"alternative-id":["10.3389\/ftox.2025.1572324"],"URL":"https:\/\/doi.org\/10.3389\/ftox.2025.1572324","relation":{},"ISSN":["2673-3080"],"issn-type":[{"type":"electronic","value":"2673-3080"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"article-number":"1572324"}}